Enterin Incis A Clinical Stage Biopharmaceutical Company Based In Philadelphiapathe Company Focuses On Developing Innovative Treatments For Neurodegenerative Diseasesparticularly By Addressing The Gut Brain Axiswhich Is Believed To Play A Significant Role In Conditions Like Parkinson S Disease Enterin S Lead Drug Candidateent 01Aims To Repair Gut Brain Axis Dysfunctionin Preclinical Modelsent 01 Has Shown Potential By Displacing Alpha Synuclein Aggregates And Restoring Normal Signaling Between The Gut And Brainthe Drug Recently Met Its Primary Endpoint In A Phase 2B Studysuggesting It May Improve Quality Of Life For Patients By Addressing Various Non Motor Symptoms Associated With Neurodegenerative Diseases The Company Is Committed To Research And Developmentfocusing On The Enteric Nervous System S Role In These Conditionsenterin Has Also Engaged Notable Experts In The Field To Support Its Mission
No conferences found for this company.
| Company Name | Enterin Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
